Numerous cancer biomarkers have been developed and utilized across various cancer types, such as carcinoembryonic antigens in lung and gastrointestinal cancers30, prostate-specific antigens in prostate cancer, and CA19-978 in pancreatic cancer31,32. This evidence concerns the gene KLK3 and prostate carcinoma.